Yijie Tang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

MTP18 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

MTP18 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

Journal: Respiratory research

Published: October 06, 2025

Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017].

Corrigendum to "Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B" [Antivi. Res. 231 (2024) 1-13/106017].

Journal: Antiviral research

Published: January 14, 2025

Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B.

Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B.

Journal: Antiviral research

Published: August 14, 2024

A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers.

A novel prognostic signature based on smoking-associated genes for predicting prognosis and immune microenvironment in NSCLC smokers.

Journal: Cancer cell international

Published: November 14, 2023

A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.

A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC.

Journal: Cancer cell international

Published: November 02, 2023

Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.

Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.

Journal: Journal of cancer research and clinical oncology

Published: October 19, 2022

The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases.

The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases.

Journal: Viruses

Published: August 30, 2022

ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma.

ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma.

Journal: Journal of thoracic disease

Published: July 26, 2022

Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration.

Characteristic of Molecular Subtypes in Lung Squamous Cell Carcinoma Based on Autophagy-Related Genes and Tumor Microenvironment Infiltration.

Journal: Journal of oncology

Published: April 02, 2022

Relieving immunosuppression by Endo@PLT targeting anti-angiogenesis to improve the efficacy of immunotherapies.

Relieving immunosuppression by Endo@PLT targeting anti-angiogenesis to improve the efficacy of immunotherapies.

Journal: Chemical communications (Cambridge, England)

Published: February 17, 2022

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.

Journal: Disease markers

Published: November 23, 2021

STEAP4 promoter methylation correlates with tumorigenesis of hepatocellular carcinoma.

STEAP4 promoter methylation correlates with tumorigenesis of hepatocellular carcinoma.

Journal: Pathology, research and practice

Published: October 14, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026